{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:27:47Z","timestamp":1715646467107},"reference-count":31,"publisher":"Pharmaceutical Society of Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2024,1,20]]},"DOI":"10.1248\/bpb.b23-00301","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T22:12:57Z","timestamp":1701900777000},"page":"213-220","source":"Crossref","is-referenced-by-count":0,"title":["Influence of Endogenous Substances on Site-II to Site-I Displacement of Diclofenac Bound to Albumin in the Aqueous Humor of Patients with Cataract"],"prefix":"10.1248","volume":"47","author":[{"given":"Saya","family":"Ishii","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Miyazaki Hospital, University of Miyazaki"},{"name":"Ozaki Eye Hospital"},{"name":"School of Pharmaceutical Sciences, Kyushu University of Health and Welfare"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineo","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Ozaki Eye Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norito","family":"Takamura","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Kyushu University of Health and Welfare"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ogata","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Kyushu University of Health and Welfare"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Tokunaga","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Kyushu University of Health and Welfare"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Miyazaki Hospital, University of Miyazaki"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Roberts CW. Comparison of diclofenac sodium and flurbiprofen for inhibition of surgically induced miosis. <i>J. Cataract Refract. Surg.<\/i>, <b>22<\/b> (Suppl. 1), 780\u2013787 (1996).","DOI":"10.1016\/S0886-3350(96)80162-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Asano S, Miyake K, Ota I, Sugita G, Kimura W, Sakka Y, Yabe N. Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%. <i>J. Cataract Refract. Surg.<\/i>, <b>34<\/b>, 57\u201363 (2008).","DOI":"10.1016\/j.jcrs.2007.08.030"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Sivaprasad S, Bunce C, Crosby-Nwaobi R. Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. <i>Cochrane Database Syst. Rev.<\/i>, <b>2<\/b>, CD004239 (2012).","DOI":"10.1002\/14651858.CD004239.pub3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Moreno-Monta\u00f1\u00e9s J, Lajara Blesa J. IgG, albumin and total IgG index in the aqueous humour of eyes with pseudoexfoliation syndrome. <i>Acta Ophthalmol. Scand.<\/i>, <b>73<\/b>, 249\u2013251 (1995).","DOI":"10.1111\/j.1600-0420.1995.tb00278.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Osaki T, Ozaki M, Takamura N, Ogata K, Tokunaga J, Setoguchi N, Arimori K. Albumin-binding of diclofenac and the effect of a site II inhibitor in the aqueous humor of cataract patients with the instillation of diclofenac. <i>Biopharm. Drug Dispos.<\/i>, <b>35<\/b>, 218\u2013227 (2014).","DOI":"10.1002\/bdd.1887"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Setoguchi N, Takamura N, Fujita KI, Ogata K, Tokunaga J, Nishio T, Chosa E, Arimori K, Kawai K, Yamamoto R. A diclofenac suppository-nabumetone combination therapy for arthritic pain relief and a monitoring method for the diclofenac binding capacity of HSA site II in rheumatoid arthritis. <i>Biopharm. Drug Dispos.<\/i>, <b>34<\/b>, 125\u2013136 (2013).","DOI":"10.1002\/bdd.1829"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Takamura N, Maruyama T, Otagiri M. Effects of uremic toxins and fatty acids on serum protein binding of furosemide: possible mechanism of the binding defect in uremia. <i>Clin. Chem.<\/i>, <b>43<\/b>, 2274\u20132280 (1997).","DOI":"10.1093\/clinchem\/43.12.2274"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Nishio T, Takamura N, Nishii R, Tokunaga J, Yoshimoto M, Kawai K. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition. <i>Nephrol. Dial. Transplant.<\/i>, <b>23<\/b>, 2304\u20132310 (2008).","DOI":"10.1093\/ndt\/gfn002"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Totoribe K, Takamura N, Ogata K, Tokunaga J, Kawai K, Nakamura K, Ieiri I, Higuchi S. Influences of artificial heart-lung machine operation on the binding sites of albumin: possibility of an effective administration plan. <i>Int. J. Artif. Organs<\/i>, <b>37<\/b>, 99\u2013108 (2014).","DOI":"10.5301\/ijao.5000299"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Lykkesfeldt J, Loft S, Poulsen HE. Determination of ascorbic acid and dehydroascorbic acid in plasma by high-performance liquid chromatography with coulometric detection\u2014are they reliable biomarkers of oxidative stress? <i>Anal. Biochem.<\/i>, <b>229<\/b>, 329\u2013335 (1995).","DOI":"10.1006\/abio.1995.1421"},{"key":"11","unstructured":"11) Asanuma K. A new method for simultaneous autoanalysis of plasma levels of lactic acid and pyruvic acid by means of the oxidase systems. <i>J. Anal. Bio-Suime<\/i>, <b>8<\/b>, 16\u201324 (1985)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Shimbo K, Kubo S, Harada Y, Oonuki T, Yokokura T, Yoshida H, Amao M, Nakamura M, Kageyama N, Yamazaki J, Ozawa SI, Hirayama K, Ando T, Miura J, Miyano H. Automated precolumn derivatization system for analyzing physiological amino acids by liquid chromatography\/mass spectrometry. <i>Biomed. Chromatogr.<\/i>, <b>24<\/b>, 683\u2013691 (2010).","DOI":"10.1002\/bmc.1346"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Yamasaki K, Rahman MH, Tsutsumi Y, Maruyama T, Ahmed S, Kragh-Hansen U, Otagiri M. Circular dichroism simulation shows a site-II-to-site-I displacement of human serum albumin-bound diclofenac by ibuprofen. <i>AAPS PharmSciTech<\/i>, <b>1<\/b>, 45\u201354 (2000).","DOI":"10.1007\/BF02830527"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Goodman DS. The interaction of human serum albumin with long-chain fatty acid anions. <i>J. Am. Chem. Soc.<\/i>, <b>80<\/b>, 3892\u20133898 (1958).","DOI":"10.1021\/ja01548a024"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) McMenamy RH, Oncley JL. The specific binding of L-tryptophan to serum albumin. <i>J. Biol. Chem.<\/i>, <b>233<\/b>, 1436\u20131447 (1958).","DOI":"10.1016\/S0021-9258(18)49353-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Mu H, Chen S, Liu F, Xiao J, Huang H, Zhang Y, Sun Y, Gao X, Lei H, Yuan X. Stereoselective interactions of lactic acid enantiomers with HSA: spectroscopy and docking application. <i>Food Chem.<\/i>, <b>270<\/b>, 429\u2013435 (2019).","DOI":"10.1016\/j.foodchem.2018.07.135"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Dr\u00f6ge JHM, Janssen LHM, Wilting J. The fatty-acid-induced conformational states of human serum albumin investigated by means of multiple co-binding of protons and oleic acid. <i>Biochem. J.<\/i>, <b>250<\/b>, 443\u2013446 (1988).","DOI":"10.1042\/bj2500443"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Nauser T, Gebicki JM. Physiological concentrations of ascorbate cannot prevent the potentially damaging reactions of protein radicals in humans. <i>Chem. Res. Toxicol.<\/i>, <b>30<\/b>, 1702\u20131710 (2017).","DOI":"10.1021\/acs.chemrestox.7b00160"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Callaghan P, Martin NH. The relation of the rotatory dispersion behaviour of human serum albumin to its configuration. <i>Biochem. J.<\/i>, <b>83<\/b>, 144\u2013151 (1962).","DOI":"10.1042\/bj0830144"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Shaklai N, Garlick RL, Bunn HF. Nonenzymatic glycosylation of human serum albumin alters its conformation and function. <i>J. Biol. Chem.<\/i>, <b>259<\/b>, 3812\u20133817 (1984).","DOI":"10.1016\/S0021-9258(17)43168-1"},{"key":"21","unstructured":"21) Oleszko A, Hartwich J, G\u0105sior-G\u0142ogowska M, Olszty\u0144ska-Janus S. Changes of albumin secondary structure after palmitic acid binding. FT-IR spectroscopic study. <i>Acta Bioeng. Biomech.<\/i>, <b>20<\/b>, 59\u201364 (2018)."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Yamasaki K, Hyodo S, Taguchi K, Nishi K, Yamaotsu N, Hirono S, Chuang VT, Seo H, Maruyama T, Otagiri M. Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin. <i>PLOS ONE<\/i>, <b>12<\/b>, e0180404 (2017).","DOI":"10.1371\/journal.pone.0180404"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Bhattacharya AA, Gr\u00fcne T, Curry S. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. <i>J. Mol. Biol.<\/i>, <b>303<\/b>, 721\u2013732 (2000).","DOI":"10.1006\/jmbi.2000.4158"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Petitpas I, Gr\u00fcne T, Bhattacharya AA, Curry S. Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. <i>J. Mol. Biol.<\/i>, <b>314<\/b>, 955\u2013960 (2001).","DOI":"10.1006\/jmbi.2000.5208"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Sj\u00f6din T. Circular dichroism studies on the inhibiting effect of oleic acid on the binding of diazepam to human serum albumin. <i>Biochem. Pharmacol.<\/i>, <b>26<\/b>, 2157\u20132161 (1977).","DOI":"10.1016\/0006-2952(77)90268-4"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Chamouard JM, Barre J, Urien S, Houin G, Tillement J. Diclofenac binding to albumin and lipoproteins in human serum. <i>Biochem. Pharmacol.<\/i>, <b>34<\/b>, 1695\u20131700 (1985).","DOI":"10.1016\/0006-2952(85)90636-7"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Chakrabarti SK. Cooperativity of warfarin binding with human serum albumin induced by free fatty acid anion. <i>Biochem. Pharmacol.<\/i>, <b>27<\/b>, 739\u2013743 (1978).","DOI":"10.1016\/0006-2952(78)90513-0"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Wilding G, Feldhoff RC, Vesell ES. Concentration-dependent effects of fatty acids on warfarin binding to albumin. <i>Biochem. Pharmacol.<\/i>, <b>26<\/b>, 1143\u20131146 (1977).","DOI":"10.1016\/0006-2952(77)90058-2"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Takamura N, Shinozawa S, Maruyama T, Suenaga A, Otagiri M. Effects of fatty acids on serum binding between furosemide and valproic acid. <i>Biol. Pharm. Bull.<\/i>, <b>21<\/b>, 174\u2013176 (1998).","DOI":"10.1248\/bpb.21.174"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Maruyama K, Awazu S, Nishigori H, Iwatsuru M. Effects of fatty acid on the specific drug-binding sites of human serum albumin. <i>Chem. Pharm. Bull.<\/i>, <b>34<\/b>, 3394\u20133402 (1986).","DOI":"10.1248\/cpb.34.3394"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Yamasaki K, Kuga N, Takamura N, Furuya Y, Hidaka M, Iwakiri T, Nishii R, Okumura M, Kodama H, Kawai K, Arimori K. Inhibitory effects of amino-acid fluids on drug binding to site II of human serum albumin <i>in vitro.<\/i> <i>Biol. Pharm. Bull.<\/i>, <b>28<\/b>, 549\u2013552 (2005).","DOI":"10.1248\/bpb.28.549"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/47\/1\/47_b23-00301\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:54:57Z","timestamp":1715576097000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/47\/1\/47_b23-00301\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,20]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b23-00301","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,20]]},"article-number":"b23-00301"}}